Effect of Transauricular Vagus Nerve Stimulation on Rebound Pain After Ropivacaine Single Injection Femoral Nerve Block for Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial
DOI: https://doi.org/10.2147/JPR.S370589
IF: 2.8319
2022-07-14
Journal of Pain Research
Abstract:Qi Zhou, 1 Lili Yu, 2 Chunping Yin, 1 Qi Zhang, 3 Yanlei Tai, 1 Lian Zhu, 4 Jiangtao Dong, 5 Qiujun Wang 1 1 Department of Anesthesiology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China; 2 Department of Anesthesiology, Cangzhou Central Hospital, Cangzhou, Hebei, People's Republic of China; 3 Department of Anesthesiology, Hebei Children's Hospital Affiliated to Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China; 4 Department of Orthopaedics, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China; 5 Department of Joint Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China Correspondence: Qiujun Wang, Department of Anesthesiology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China, Email Purpose: The aim of this study was to investigate whether transauricular vagus nerve stimulation (taVNS) could reduce the incidence of rebound pain in patients undergoing anterior cruciate ligament reconstruction (ACLR) under general anesthesia combined with preoperative femoral nerve block. Methods: In total, 78 patients were enrolled in this prospective, randomized, double-blind, and sham-controlled study. Patients were randomly assigned to 2 groups (n=39): Group taVNS received taVNS (1h /1time, 6times) within the first 12 h after surgery; Group SS received sham stimulation (SS) in the same manner. Pain scores at 0, 4, 8, 12, 24, 48 h after surgery were assessed with Numeric Pain Rating Scale (NRS). The incidence, duration and onset of rebound pain were recorded. In addition, additional analgesic requirements and side effects in the first 48 h postoperatively, as well as sleep disturbance on the night of surgery, were examined. Results: The incidence and duration of rebound pain were lower in the taVNS group than in the SS group ( P =0.025 and P =0.015, respectively). Pain scores at 8 h and 12 h postoperatively were significantly lower in the taVNS group compared with the SS group ( P < 0.05). The number of times to press the patient-controlled analgesia (PCA) pump and the number of patients requiring additional analgesic were significantly lower in the taVNS group than in the SS group until 12 h after surgery ( P =0.021 and P =0.004, respectively). The number of patients with sleep disturbance in the taVNS group was lower than that in the SS group ( P =0.030). Conclusion: The taVNS exerts beneficial effect on rebound pain after femoral nerve block in patients undergoing ACLR, which reduces the incidence and duration of rebound pain, the need for postoperative additional analgesic, and the number of complications. Keywords: rebound pain, transauricular vagus nerve stimulation, femoral nerve block, anterior cruciate ligament reconstruction Peripheral nerve blocks (PNBs) are widely used in orthopedic surgery to reduce perioperative pain and opioid consumption. 1 Recently, however, an increasing number of anesthesiologists and surgeons are concerned about the rebound pain associated with PNB. 2 Rebound pain is defined as "quantifiable difference in pain scores when the block is working versus the increase in acute pain encountered during the first few hours after the effects of PNB resolve", characterized by persistent burning pain. 2–4 The incidence of rebound pain is approximately 50% in patient received PNB. 5 Risk factors for rebound pain include younger age, female gender, higher preoperative pain score, and bone surgery. 5,6 In addition, rebound pain is associated with adverse consequences, including impaired quality of recovery, increased opioid consumption, side effects of opioid overdose, and sleep disturbance. 7 The pathophysiology of rebound pain has not been fully understood and no effective precautions and treatments are available currently. 8 Continuous PNB and perineural dexamethasone in single injection PNB have been suggested to prevent rebound pain. 3,9,10 However, there are many concerns with these strategies because persistent PNB hinders rehabilitation and the perineural use of dexamethasone is off-label. Therefore, it is necessary to understand the pathogenesis of rebound pain and provide new insights for prevention and treatment. The rebound pain may be caused by multiple pathogenic mechanisms, such as surgical mechanical injury, proinflammation and neurotoxicity of local anesthetics retention and amplification of nociceptive signal memory when PNB wear off, or -Abstract Truncated-
clinical neurology